CVS Health’s CVS Pharmacy & Consumer Wellness (“PCW”) unit includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. It ...

Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from diet and exercise following the birth of her two daughters, Olympia and ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous glucose monitor, the Dexcom Stelo Biosenor.

Serena Williams says GLP-1 medications helped her lose 31 pounds.

Eli Lilly and Company’s LLY stock has declined 5.1% so far this month, despite announcing strong second-quarter results on ...

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

Eli Lilly’s LLY 38% revenue growth and 61% non-GAAP EPS growth in the second quarter were above consensus expectations. Management raised 2025 guidance to ranges of $60 billion-$62 billion in revenue ...

People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...

Novo Nordisk A/S climbed 3.72% during Friday's pre-market trading session, after rival Eli Lilly 's Phase 3 ATTAIN-1 trial for obesity drug, orforglipron trailed the Danish drug giant's semaglutide.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly Earnings: Weak Orforglipron Obesity Data Weighs Down a Strong Quarter With today’s share drop, we think Lilly stock looks fairly valued.